You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Generics
Endo commences manufacturing Novavax's potential COVID-19 vaccine
Login
Username:

Password:


Related Headlines

CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension

Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months

ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets

Newbury Pharmaceuticals secures approval for Macitentan in Denmark

Mallinckrodt and Endo to merge in USD6.7bn deal to create pharmaceutical leader

Genomma Lab Internacional announces quarterly dividend

Veloxis Pharmaceuticals announces US approval of 'pegrizeprument' as non-proprietary name for VEL-101

Aveva Drug Delivery systems introduces generic Fentanyl Transdermal Patch in US

Independent Pharmacy Cooperative signs cooperation agreement with Legacy Pharmacy Group

ILIKOS Consulting partners with Jordan Center for Pharmaceutical Research

Axsome Therapeutics settles patent litigation with Teva over AUVELITY

Breckenridge Pharmaceutical's Everolimus Tablets for Oral Suspension receive US FDA approval

Newbury Pharmaceuticals secures generic approval for pomalidomide in Denmark

Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway

Guangzhou Fermion Technology partners with Simcere Pharmaceutical

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025